11.48MMarket Cap
LossP/E TTM
Key Figures
1.080Open
1.080High
239.80KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
2.23%Turnover Ratio
1.060Prev. Close
1.000Low
204.21KTurnover
LossP/E Static
0.26P/B
0.00%Div Yield TTM
-44.12%ROA
5.50052wk High
2.22Volume Ratio
-112.02MNet Profit
10.74MShares
-4.4524EPS TTM
1.65Beta
-73.78%ROE
1.06052wk Low
7.55%Amplitude
48.63%Gross Margin
11.48MMarket Cap
-1.85Reward/Risk
4.23%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Bionano Genomics Inc's fundamentals are relatively stable, and its growth potential is significant.Its valuation is considered fairly valued, ranking 104 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 5.00.In the medium term, the stock price is expected to trend down.The company has shown weak stock market performance over the past month, in line with its weak fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Bionano Genomics Inc's Score
Support & Resistance

Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Bionano Genomics Inc Highlights
StrengthsRisks
Bionano Genomics Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Intuitive Surgical Inc
ISRG
35
Boston Scientific Corp
BSX
34
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
29
Indicators
Financial Indicators
EPS

Relevant data have not been disclosed by the company yet.
Total revenue

Relevant data have not been disclosed by the company yet.
Bionano Genomics Inc Info
Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).
Ticker SymbolBNGO
CompanyBionano Genomics Inc
CEOHolmlin (R. Erik)
Websitehttps://bionano.com/
Shareholders
FAQs
What is the current price of Bionano Genomics Inc (BNGO)?
The current price of Bionano Genomics Inc (BNGO) is 1.07.
What is the symbol of Bionano Genomics Inc?
The ticker symbol of Bionano Genomics Inc is BNGO.
What is the 52-week high of Bionano Genomics Inc?
The 52-week high of Bionano Genomics Inc is 5.50.
What is the 52-week low of Bionano Genomics Inc?
The 52-week low of Bionano Genomics Inc is 1.06.
What is the market capitalization of Bionano Genomics Inc?
The market capitalization of Bionano Genomics Inc is 11.48M.
Is Bionano Genomics Inc (BNGO) currently rated as Buy, Hold, or Sell?
According to analysts, Bionano Genomics Inc (BNGO) has an overall rating of Buy, with a price target of 5.00.
What is the Earnings Per Share (EPS TTM) of Bionano Genomics Inc (BNGO)?
The Earnings Per Share (EPS TTM) of Bionano Genomics Inc (BNGO) is -4.85.